ISSUE: 2000/02/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers

References: Basic Science / Neuroblastoma Research

References: Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Previous Issue of Recent Publications (2000/01/b)

Next Issue of Recent Publications (2000/03/a)

Back to NBL-PROF Home Page

Clinical / Prognostic Markers

Diaz MA, et al. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors. Bone Marrow Transplant. 1999 Dec;24(11):1157-9.    [Related articles]

Frappaz D, et al. LMCE3 Treatment Strategy: Results in 99 Consecutively Diagnosed Stage 4 Neuroblastomas in Children Older Than 1 Year at Diagnosis. J Clin Oncol. 2000 Feb;18(3):468.    [Related articles]     Trials & Studies

Granata C, et al. Features and outcome of neuroblastoma detected before birth. J Pediatr Surg. 2000 Jan;35(1):88-91.    [Related articles]

Kreeftenberg HG Jr, et al. Scrotal hematoma, anemia, and jaundice as manifestations of adrenal neuroblastoma in a newborn. J Pediatr Surg. 1999 Dec;34(12):1856-7.    [Related articles]

Kubota M, et al. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma. J Pediatr Surg. 2000 Jan;35(1):92-5.    [Related articles]

Nickerson HJ, et al. Favorable Biology and Outcome of Stage IV-S Neuroblastoma With Supportive Care or Minimal Therapy: A Children's Cancer Group Study. J Clin Oncol. 2000 Feb;18(3):477.    [Related articles]

Olshan AF, et al. Neuroblastoma and parental occupation. Cancer Causes Control. 1999 Dec;10(6):539-49.    [Related articles]

Perez CA, et al. Biologic Variables in the Outcome of Stages I and II Neuroblastoma Treated With Surgery as Primary Therapy: A Children's Cancer Group Study. J Clin Oncol. 2000 Jan;18(1):18.    [Related articles]     Trials & Studies

Basic Science / Neuroblastoma Research

Bieberich E, et al. N-Acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cells. J Biol Chem. 2000 Jan 7;275(1):177-81.    [Related articles]

Borriello A, et al. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation. Oncogene. 2000 Jan 6;19(1):51-60.    [Related articles]

Canete A, et al. Angiogenesis in Neuroblastoma: Relationship to Survival and Other Prognostic Factors in a Cohort of Neuroblastoma Patients. J Clin Oncol. 2000 Jan;18(1):27.    [Related articles]

Chambaut-Guerin AM, et al. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation. J Neurochem. 2000 Feb;74(2):508-17.    [Related articles]

Damle RN, et al. Antiproliferative activity of conditioned medium from lymphocytes of neuroblastoma (NB) patient and inhibition with NB serum. Cancer Lett. 1999 Dec 1;147(1-2):5-10.    [Related articles]

Davy A, et al. Signaling within a caveolae-like membrane microdomain in human neuroblastoma cells in response to fibroblast growth factor. J Neurochem. 2000 Feb;74(2):676-83.    [Related articles]

Eggenberger M, et al. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells. Neuropeptides. 1999;33(2):107-114.    [Related articles]

Ferrari L, et al. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours. Anticancer Res. 1999;19(4C):3415-27. Review.    [Related articles]

Frangez R, et al. Equinatoxin II increases intracellular Ca2+ in NG 108-15 cells. Pflugers Arch. 2000;439(3 Suppl):R100-1.    [Related articles]

Girgert R, et al. Inhibition of farensyl-protein-transferase in neuroblastoma cells by alpha-hydroxyfarnesylphosphonate. Anticancer Res. 1999; 19(4B):2959-62.    [Related articles]

Halbfinger E, et al. Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach. J Med Chem. 1999 Dec 30;42(26):5325-37.    [Related articles]

Ho LH, et al. Involvement of Intracellular Labile Zinc in Suppression of DEVD-Caspase Activity in Human Neuroblastoma Cells. Biochem Biophys Res Commun. 2000 Feb 5;268(1):148-154.    [Related articles]

Hynds DL, et al. Neurite outgrowth inhibition by chondroitin sulfate proteoglycan: stalling/stopping exceeds turning in human neuroblastoma growth cones. Exp Neurol. 1999 Nov;160(1):244-55.    [Related articles]

Katzenstein HM, et al. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden. Clin Cancer Res. 1999 Dec;5(12):4273-8.    [Related articles]

Keshelava N, et al. Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines. Cancer Chemother Pharmacol. 2000;45(1):1-8.    [Related articles]

Kim SN, et al. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells. J Cell Physiol. 2000 Mar;182(3):421-8.    [Related articles]

Knezevic-Cuca J, et al. Neurotrophic role of interleukin-6 and soluble interleukin-6 receptors in N1E-115 neuroblastoma cells. J Neuroimmunol. 2000 Jan 3;102(1):8-16.    [Related articles]

Matsui T, et al. Differentiation-inducing effect of thymidine on human neuroblastoma cells. Anticancer Res. 1999;19(4B):3037-44.    [Related articles]

McKenzie PP, et al. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated. Clin Cancer Res. 1999 Dec;5(12):4199-207.    [Related articles]

Misawa A, et al. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res. 2000 Jan 1;60(1):64-9.    [Related articles]     MYCN Amplification

Nikolopoulos SN, et al. The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene. 2000 Jan 20;19(3):380-6.    [Related articles]

Olivieri G, et al. Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J Neurochem. 2000 Jan;74(1):231-6.    [Related articles]

Pagnan G, et al. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects. J Natl Cancer Inst. 2000 Feb 2;92(3):253-61.    [Related articles]

Panarello C, et al. Full cytogenetic characterization of a new neuroblastoma cell line with a complex 17q translocation. Cancer Genet Cytogenet. 2000 Jan 15;116(2):124-32.    [Related articles]     Chromosome 17q

Perez-Juste G, et al. An Element in the Region Responsible for Premature Termination of Transcription Mediates Repression of c-myc Gene Expression by Thyroid Hormone in Neuroblastoma Cells. J Biol Chem. 2000 Jan 14;275(2):1307-1314.    [Related articles]

Veerhuis R, et al. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol. 1999;160(1):289-99.    [Related articles]

Yasuno T, et al. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line. Anticancer Res. 1999;19(5B):4049-57.    [Related articles]

Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Nakamura M, et al. APO2L/TRAIL expression in human brain tumors. Acta Neuropathol (Berl). 2000 Jan;99(1):1-6.    [Related articles]

Salim H, et al. Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells. J Neurochem. 2000 Jan;74(1):432-9.    [Related articles]

Storch A, et al. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 2000 Feb 7;855(1):67-75.    [Related articles]

Tanii H, et al. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis. Neuroscience. 2000;95(2):593-601.    [Related articles]

Previous Issue of Recent Publications (2000/01/b)
Next Issue of Recent Publications (2000/03/a)
Back to NBL-PROF Home Page